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Abstract
Background/Aims:  Analysis of gene expression in renal tissue is considered to be a diagnostic 
tool predicting the clinical course of glomerulonephritis. The present study quantified the 
relative transcript levels of VEGF, CTGF and HIF-1α in renal tissue to establish their relationship 
with some clinical variables in patients suffering from chronic glomerulonephritis (CGN). 
Methods: 28 patients (6F and 22M, mean age 51.2±15.0) with CGN were enrolled. Type 
of CNG recognized by kidney biopsy (histopatological evaluation) was as follows: minimal 
change disease (MCD)-3pts, IgA nephropathy-5pts, FSGS-3pts, membranous nephropathy-
4pts, mesangio-proliferative glomerulonephritis-3pts; MPGN-1pts, lupus nephritis-6pts, 
granulomatosis with polyangitis-2 pts; hypertensive nephropathy- 3pts. Renal tissue from 3 
individuals with normal eGFR and histology was taken as control. Mean clinical follow-up of 
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at the time of biopsy and then in 6 months intervals. Real-time PCR was used to determine 
relative gene expression. The housekeeping gene GAPDH was used as normalization control. 
Results: At the time of the biopsy relative expression of 3 analyzed genes was diminished in 
comparison to control. There were statistically significant differences in VEGF gene relative 
expression level in patients which varied according to eGFR and tendency in patients which 
varied according to DPE. HIF-alfa and CTGF gene showed only a tendency. Conclusions: 
Overexpression of the VEGF gene in subjects with DPE>3,5g may  point to  insufficient oxygen 
supply in renal tissue which may result in tubulointerstitial fibrosis with further functional renal 
impairment and decline of eGFR. 
 Copyright © 2014 S. Karger AG, Basel
Introduction
Percutaneous fine-needle kidney biopsy is considered to be a gold standard in 
the diagnostics of kidney diseases. Histological analysis of renal tissue may be helpful 
in detecting its structural changes, both in the glomerular and the tubulointerstitial 
compartment. The assessment of  immunoglobulin and complement fractions is an integral 
part of this evaluation. Novel diagnostics approach in kidney diseases compromise: gene 
expression analysis of renal tissue samples obtained during kidney biopsy, and analysis of 
urinary proteins, mainly low molecular weight proteins (LMWP) the excretion of which may 
correlate with severity of tubulointerstitial lesions. [1].   
The analysis of mRNA level for molecules known to be involved in pathogenesis 
of tubulointerstitial lesions may be helpful as prognostic tool in renal diseases and can 
correlate with the slope of renal function determined by eGFR measurements [2]. Gene 
expression data usually correlate with clinical course and biopsy histology, and they provide 
potential insight into the “cellular programme” of the underlying disease [3, 4]. Moreover, 
the upregulation of intrarenal genes expression may precede structural alterations. In our 
study we wanted to evaluate the relative expression of VEGF (vascular endothelial growth 
factor), CTGF (connective tissue growth factor) and HIF-1α (hypoxia inducible factor 1α), 
genes, which play a role in regulating angiogenic, fibrogenic, inflammatory, and apoptotic 
renal processes [5-8].  
Material and Methods
28 patients (pts) (6F and 22M, mean age 51.2±15.0) with mostly primary chronic glomerulonephritis 
(CGN) recognized in kidney biopsy were investigated. In each individual, 3 tissue specimens were collected. 
Histopathological and immunohistological evaluation of renal tissue samples was performed. Each specimen 
was considered to be representative as it contained more than 10 glomeruli. Molecular analysis was carried 
out in Biotechnology Department of Nicolaus Copernicus University in Toruń. Indications for renal biopsy 
were: nephrotic syndrome, proteinuria of less than 3,5g per day,  hematuria (without hematuria of urological 
origin), rapid decline in renal function (RPGN) associated with changes in urinalysis. Histopatological 
characteristics of patients are presented in Table 1. Renal tissue from 3 individuals with normal renal 
function and histology was used as a control.  The normal renal tissue samples were obtained during total 
nephrectomy performed after diagnosis of renal tumors. The control tissue was obtained from kidneys with 
no evidence of tumor obstruction or vessel invasion. The samples were obtained from areas remote from 
the malignancies. All studied subjects had no history of hypertension or renal disease. 
Median clinical follow-up of patients was 12 months after biopsy procedure. eGFR (ml/min)  using 
the MDRD equation was calculated. eGFR was followed for 12 months at 6 months intervals (To-T6-T12). 
Mean values were:  eGFR0 -55.8±31.5; eGFR6- 55.1± 28.8; eGFR12 – 54.7±30.5 respectively. Daily urinary 
protein excretion (DPE) was evaluated at the time of the biopsy and was expressed in g/24h.  Mean values 
calculated at 6 months intervals were: DPE0- 5.48±5.15; DPE6 -3.37±3.43; DPE12 1.58±1.88 respectively. 
Hypertension was diagnosed in 23 patients (82,1%). They were treated with ACE-I – 23 pts; AT II 
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Histopathological evaluation
Two renal tissue samples obtained from the left kidney were sent to the Department of Clinical 
Pathology of the Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. After fixing in 10% 
formalin overnight paraffin block was prepared (one formalin fixed specimen). Hematoxylin-eosin, 
trichrome Masson, Congo red staining and PAS reaction were performed on deparaffinized and dehydratated 
paraffin tissue sectioned at 4-µm thickness. The other specimen were left unfixed for immunofluorescence 
examination. The tissue sample was frozen at -30°C. In 4 µm tissue sections the IgG, IgM, IgA, C3 and 
fibrinogen were determined by means of fluorescein-labeled anti-human serum. 
Molecular analysis
Renal tissue samples were taken from each patient during routine biopsy procedure for real-time 
polymerase chain reaction (RT-PCR) assessment of the mRNA levels for investigated genes. The samples 
were transported in liquid nitrogen or RNalater solution, then stored at the temperature of -80˚C for 
subsequent RNA extraction performed in the Department of Biotechnology, Nicolaus Copernicus University. 
Sample preparation
Buffer RLT (Qiagen) was used for the lysis of homogenized tissues before RNA isolation. Total 
cellular RNA was extracted from samples with the use of TRIzol reagent (Invitrogen) in accordance 
with the manufacturer’s protocol. RNA was additionally purified with DNase I (Fermentas) and phenol–
chloroform extraction. RNA quality and quantity were confirmed with agarose gel electrophoresis and 
spectrophotometry (NanoDrop). 4 µg of the purified RNA was reverse transcribed by using the Transcriptor 
High Fidelity cDNA Synthesis Kit (containing reverse transcriptase and random primer hexamers), 
following the manufacturer’s recommendations (Roche). In order to assess the quality of the obtained cDNA 
and the specificity of the primers, and to develop appropriate reaction conditions, especially the annealing 
temperature of primers for each gene, a conventional PCR was performed.
Quantitative RT-PCR
The following primers have been used to measure RNA abundance (5` to 3`): 
VEGF forward primer: AAGGCTGAGCTGGAGGAAG, VEGF reverse primer: GGAGCATGATTGAGACTCGC 
CTGF forward primer: TGACCGCCGCCAGTAT, CTGF reverse primer: GAGGAGGACCACGAAGGC
HIF1α forward primer: TGCTCATCAGTTGCCACTTC, HIF1α reverse primer: CCAAGCAGGTCATAGGTGGT
GAPDH forward primer: GAGTCAACGGATTTGGTCGT, 
GAPDH reverse primer: TTGATTTTGGAGGGATCTCG.
We used the housekeeping gene GAPDH (glyceraldehyde 3-phosphate dehydrogenase) as normalization 
control. The comparative cycle time (Ct) value of the target PCR was normalized by subtracting the Ct value of 
GAPDH.  Each reaction contained 1 μl standard/cDNA template, 0.1 μl each primer for the gene (final concentration 
0.3 μM), 8.8 μl water, and 10 μl FastStart SYBR Green Master following the standard PCR program suggested 
by the manufacturer (Roche). The reactions were carried out on a Quantica instrument (Techne), using the 
following temperature program: 95°C for 10 minutes (activation of FastStart Taq DNA Polymerase), then 40 
Table 1. Histological characteristics of patientsmeasurements was SBP-137,5±10,2mmHg and DBP-
86,52±7,59mmHg. Renal anemia  (HB concentration 
<13,0g/dl in males and <12,0g/dl in females) 
was diagnosed at the time of kidney biopsy in 6 
individuals.  These were cases of rapid progressive 
glomerulonephritis (RPGN) related to lupus nephritis 
and vasculitis. Immunosuppressive agents were 
administered to 19 patients in accordance with biopsy 
findings suggesting active renal lesions. The treatment 
was carried out accordingly to current standards.  
The study protocol was approved by the local 
Bioethics Committee of the Nicolaus Copernicus 
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cycles of 95°C for 15 seconds, 61°C for 15 seconds and 72°C for 30 seconds. The reactions were performed 
in duplicate. 
The amplification of the target sequence was detected using SYBR Green dye. Melting curve analyses 
were performed to verify the amplification specificity. At first, quantitative PCR reactions were carried out on 
a dilution series of a standard to obtain standard curves for both target and control genes. Concentrations of 
standards were determined by measuring the absorbance at 260 nm using a NanoDrop spectrophotometer. 
The analysis was performed on serially diluted samples in triplicate. The specificity of the reaction was 
examined by analysis of the melting curve of the final amplified product. After 40 cycles, a melting curve 
was generated by increasing (by 0.5°C) the temperature from 70°C to 90°C, while the fluorescence was 
measured. The threshold cycle (Ct) was calculated based on the Second Derivative Maximum method using 
the Quansoft Software (Techne) by determining the cycle number at which the change in the fluorescence 
crossed the threshold. The qRT-PCR data were plotted as fluorescence signal versus cycle number. The 
relative level of expression was calculated using the Pfaffl method:
Statistical analysis
Results are expressed as mean ± SD. The relative gene expression levels are presented as n-fold 
difference relative to the control. Gene expression of the control group in the comparative CT method always 
equals one. The data obtained were compared using Mann-Whitney non-parametrical tests. For all the tests 
p value of <0.05 was considered as statistically significant.
Results 
Real-time PCR was used to determine the relative level of expression of selected genes. 
An ongoing experiment, we used non-specific detection of double-stranded DNA using SYBR 
Green dye.
For the purpose of analysis the following were used:
- standard curves (for the assessment of efficiency of reaction) (Figure 1A),
- amplification curves (allowing the determination of the threshold cycle Ct) 
  (Figure 1B),
- melting curves of reaction products (for an analysis of the specificity of the 
   amplicon synthesized) (Figure 1C).
The obtained gene activity expression data  were normalized to the housekeeping 
gene - GAPDH.
The levels of VEGF, CTGF, HIF1α  in the investigated group (black bars) and the control 
group (grey bars) were measured relative to GAPDH. The ratio of target genes to GAPDH is 
shown on the y-axis, the gene type analyzed is shown on the x-axis. Expression of VEGF, CTGF, 
and HIF1α was normalized to internal housekeeping gene control (GAPDH) using the Pffafl 
method (Figure 1). The relative expression level of 3 analyzed genes was evaluated in CGN 
patients (Table 2). In all analyzed tissue samples the relative expression level of investigated 
genes was lower in comparison to the control group. VEGF sample group was different 
from the control group. [P(H1)=0,003.] We found a trend toward lower expression level 
of CTGF (0,57) and HIF-1α (0,61) in the investigated group in comparison to control group 
(Figure 2). No statistical significance was discovered (Table 2). A higher relative expression 
of VEGF gene without statistical significance was found in pts with DPE>3,5g. (p<0,064) 
(Figure 3). We also found tendency toward higher relative gene expression for CTGF and 
HIF-alfa gene in pts with DPE>3,5g (without statistical significance). We found statistically 
significant differences in the relative expression of VEGF gene between groups with 
eGFR>60ml/min and eGFR<60ml/min (p<0,02), (Figure 4). VEGF overexpression was 
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observed in CTGF and HIF-1 alfa. There was only a tendency. Patients’ age, gender, or the 
presence of hypertension had no influence on the relative VEGF expression level except for 
DPE (p<0,06) and eGFR (p<0,02) (Mann-Whitney test). Patients’ age, gender, DPE, eGFR, or 
presence of hypertension had no influence on the relative CTGF and HIF-1 alfa expression 
levels. No statistically significant differences in relative expression levels for VEGF, CTGF, 
HIF-1α were observed in a subset of glomerulonephritis with different histopathological 
pattern.  Such evaluation was performed on 3 subgroups with the highest number of patients 
(IgA nephropathy, membranous nephropathy lupus nephritis).  
Fig. 1. Real-time 
RT-PCR of VEGF 
and reference 
gene. A – Standard 
curve for VEGF 
amplification. The 
curve is based on 
values obtained 
for decreasing 
serial dilutions of 
the sample cDNA; 
B – Amplification 
curves (the graph 
shows the ampli-
fication profiles of 
VEGF and GAPDH 
present in clinical 
samples. X axis, 
number of ampli-
fication cycles, Y 




was run twice. C – 
melting curves for 
VEGF and GAPDH.
Table 2. Results of relative 
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differences in VEGFR-2 expression in comparison to control. VEGF plays a crucial role in the 
pathogenesis of proteinuria in MCD and other renal diseases associated with proteinuria. It is 
postulated that lower VEGF expression in MCD leads to the dysregulation of the renal repair 
process and it is thus impossible to maintain normal glomerular structure and function 
of capillary wall [9]. This may lead to persistent proteinuria. Shulman and co-workers 
demonstrated decreased VEGF expression in renal biopsies for different renal diseases (IgA 
nephropathy, SLE, MCD, amyloidosis, membranous glomerulonephritis, FSGS) in the sclerotic 
area, the area of marked amyloid deposition, and the area of crescent formation. In normal 
glomeruli in MCD there was a strong VEGF expression. Other investigators found increased 
VEGF expression not only in MCD but in other glomerular diseases as well [10]. In normal 
condition VEGF is an important microvascular permeability inducer release of which should 
be under strict control. In different glomerular diseases damage of visceral epithelial cells 
causes the enhancement of local VEGF release which in turn leads to increased glomerular 
permeability and alterations in glomerular endothelial cell function. Up-regulation of VEGF 
expression is involved in response to many renal pathologies such as diabetic nephropathy, 
FSGS, membranoproliferative and membranous glomerulonephritis [11]. It is difficult to 
Fig. 4. Comparison of VEGF relative expression be-
tween control group and patients with GFR ≤60ml/
min and GFR>60ml/min. Patients with GFR ≤60ml/
min showed significantly lower VEGF relative ex-
pression in compare to patients with GFR >60ml/
min (p<0,022). 
Fig. 3. Comparison of VEGF relative expression be-
tween control group and patients with different dai-
ly protein expression (DPE). Patients with DPE ≥3,5g 
showed higher VEGF relative expression in compare 
to patients with DPE ≤3,5g.  (p<0,064). 
Fig. 2. Expression of analyzed genes in renal biop-
sies. 
Discussion
In patients with CKD, irrespective of 
its primary origin, many profibrogenic and 
proinflammatory cytokines and growth 
factors are involved in irreversible renal 
scarring, determining the future prognosis.  
We found decreased relative expression 
of VEGF gene in comparison to control 
in all investigated patients regardless of 
histopathological type of glomerulonephritis. 
There are conflicting data concerning VEGF 
gene expression in kidney diseases.  Boner et 
al. in a study of 8 patients with minimal change 
disease (MCD), using in situ hybridization in 
renal biopsy, found diminished VEGF gene 
expression in comparison to control. As a 
control they used normal renal tissue from 
areas without renal tumors. Simultaneously, 
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say whether it is a primary or a secondary process related to the nature of nephropathy. 
Futhermore, it is postulated that some inflammatory cytokines may be involved in VEGF 
expression. Some of them such as IL-10 and IL-13 inhibit vascular permeability, and others 
such as IL-12 and IL-15 increase vascular permeability [12]. Besides, these inflammatory 
cytokines, other cytokines and growth factors such as TGF-β, PDGF, IL-6, IL-1β may increase 
VEGF expression [13]. In our study we found overexpression of VEGF gene in patients with 
substantial proteinuria (DPE>3,5g), (Figure 3).   There are several well-known stimuli 
for VEGF release from the endothelial surface in renal diseases i.e. hypoxia, HIF-1 alfa, 
proteinuria. Increased VEGF expression may be beneficial as it may exert protective effect 
on renal tubules and stimulate peritubular microcirculation and peritubular blood flow via 
an increase in NO synthase expression. Moreover, we know that VEGF may halt peritubular 
capillary rarefaction. Therefore, VEGF administration may be a challenging method of 
treatment in renal patients. It is important to mention that high proteinuric patients (>3,5g) 
with the highest intraglomerular pressure may show higher degree of filtration barrier 
damage and thus higher VEGF expression level and VEGF release from the endothelium [14]. 
Another important issue is deficiency in oxygen delivery to renal tissue in high proteinuric 
patients and activation of HIF -1α pathway which stimulate VEGF expression. Therefore, 
overexpression of VEGF may indicate poor oxygen delivery which may in turn lead to 
tubulointerstitial fibrosis and further eGFR decline. On the other hand, there has been some 
evidence of decreased VEGF expression in overt diabetic nephropathy and it was associated 
with reduction in peritubular capillaries density. Significant inverse correlation between 
VEGF and proteinuria was reported [15]. In our study we reported statistically significant 
VEGF overexpression in pts with eGFR>60ml/min compared to pts with eGFR<60ml/min 
(Figure 4).  That may be a sign of early lesions in the tubulointerstitial compartment. VEGF 
overexpression may precede renal tissue fibrosis and decline in eGFR. In the preliminary 
phase of kidney injury, as we mentioned before, increased VEGF expression may be observed 
and may exert a beneficial effect on renal microcirculation. Afterwards decreased VEGF 
expression may be observed and recognized, as a sign of angiogenesis impairment, capillary 
loss and development of glomerulosclerosis and interstitial fibrosis [16].
We found a tendency to overexpression of 2 other genes –CTGF and HIF-1α in pts 
with DPE>3,5g. CTGF plays an important role in the development of glomerular and 
tubulointerstitial fibrosis and it is overexpressed, especially in diabetic nephropathy, chronic 
allograft nephropathy. In normal kidney the cellular source of CTGF are podocytes. In human 
kidney diseases CTGF is produced by mesangial cells and tubular epithelial cells which 
leads,  respectively to glomerulosclerosis and interstitial fibrosis [17].  Ito et al. analyzing 
65 renal biopsies pointed out overexpression of CTGF in the extracapillary space and severe 
mesangial proliferative lesions of crescentic glomerulonephritis, IgA nephropathy, FSGS and 
diabetic nephropathy. In correlation with histopathological findings, CTGF up-regulation 
was mainly observed in the sites of tubulointerstitial damage and it correlates with the 
degree of damage [18]. In our study, we found increased HIF-1α gene expression (without 
statistical significance) in pts with clinically important proteinuria. HIF system (composed 
of 2 units: HIF1 and HIF2)  interacts with transcription process of more than 100 genes, 
which are involved in, for example, glycolysis, angiogenesis, erythropoiesis, stimulation of 
collagen synthesis and cell cycle regulation or cell survival [19-21]. Rudnicki and co-workers 
identified up-regulation of HIF-1α in renal tissue of progressive kidney disease patients. 
The expression of HIF-1α correlated positively with the level of proteinuria whereas the 
expression of VEGF-A was negatively correlated to proteinuria [22]. There was no correlation 
between HIF-1α and the degree of interstitial fibrosis. VEGF-A expression was decreased in 
progressive patients in this study [22].  In our study, HIF-1α gene expression was higher in 
renal anemia patients compared to the rest of patients without anemia at the time of kidney 
biopsy. Increased HIF-1α gene expression as an answer to low oxygen delivery in renal tissue 
may exert protective role and attenuate kidney damage. On the other hand the activation of 
HIF-1α pathway in renal epithelial cells may promote renal fibrosis and the development of 
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Conclusion
Recent publications suggest diminished, normal or increased expression level of 
analyzed genes in comparison to control. In our study we found a lower level of relative 
expression of all investigated genes in the whole population of 28 pts but there was a 
trend toward increased VEGF, CTGF, HIF-1α in the subpopulation with DPE>3,5g, and VEGF 
overexpression in pts with eGFR >60ml/min. It should be remembered that we assessed 
relative gene expression in relation to control - normal renal tissue outside the tumor (based 
on histopathological evaluation). It is postulated that such tissue as a control may result 
in spuriously high level of, for example, VEGF mRNA and may thus affect the results of our 
study. High level of VEGF is detected in the area of surrounding the tumor. In theory, it is hard 
to exclude the influence of tumor metabolism products on the rest of renal tissue. A possible 
explanation for reduced gene expression observed in our study may be suspected superiority 
of other cytokines, growth factors such as, for example, FIH 1 (not evaluated in conducted 
study). The limitation of the study was inability to implement certain novel methods, such as 
laser microdissection analysis to analyzed gene expression separately in the glomerular, and 
the interstitial compartment [24, 25]. Data from other studies indicate that such evaluation 
should be considered.  In our opinion, it is worth mentioning  that a trend to higher level 
of relative VEGF gene expression in subjects with DPE>3,5g (and a trend toward a higher 
expression of 2 others genes) was detected.  This may indicate oxygen supply deficiency 
in renal tissue which may result in tubulointerstitial fibrosis with further renal function 
impairment and eGFR decline in the near future. Therefore, this kind of diagnostic procedure 
may be valuable for prognosis the natural course of renal diseases. 
In spite of the fact that molecular analysis is not performed as a routine procedure and 
quantitative molecular analyses are made in research settings, because of its informational 
value it can prove a popular clinical tool.  Such molecular approach may be valuable not only 
in CKD patients undergoing conservative treatment but also in transplanted subjects when 
determining early allograft fibrosis. 
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